Psychotropic medication use for behavioral symptoms of dementia
- PMID:17074284
- DOI: 10.1007/s11910-006-0051-6
Psychotropic medication use for behavioral symptoms of dementia
Abstract
Behavioral disturbances associated with dementia are common and burdensome. Although no psychotropic medications are currently approved by the US Food and Drug Administration (FDA) to treat such behavioral symptoms, a variety of drug classes are commonly used for these purposes. Atypical antipsychotic medications may be somewhat effective and are generally considered the pharmacologic treatments of choice; however "black box" warnings have recently been added to their labels by the FDA, warning of significantly increased risks of short-term mortality. Older conventional antipsychotic medications may also be somewhat effective but appear to pose risks that can be at least as great as those of the newer atypical drugs. Although antidepressants, benzodiazepines, mood stabilizers, acetylcholinesterase inhibitors, and N-methyl-D-aspartate (NMDA) receptor antagonists may be considered, particularly in patients with specific types of symptomatology, even less is known about their effectiveness and safety. Also, although various psychotropic medications used for behavioral disturbances in dementia patients may be somewhat effective, they have been increasingly associated with important safety risks.
Similar articles
- Controversies in behavioral neurology: the use of atypical antipsychotic drugs to treat neurobehavioral symptoms in dementia.Kirshner HS.Kirshner HS.Curr Neurol Neurosci Rep. 2008 Nov;8(6):471-4. doi: 10.1007/s11910-008-0075-1.Curr Neurol Neurosci Rep. 2008.PMID:18957183
- Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.Stepanova E, Dowling S, Phelps M, Findling RL.Stepanova E, et al.Dialogues Clin Neurosci. 2017 Dec;19(4):395-402. doi: 10.31887/DCNS.2017.19.4/rfindling.Dialogues Clin Neurosci. 2017.PMID:29398934Free PMC article.Review.
- Managing Behavioral and Psychological Symptoms of Dementia.Gerlach LB, Kales HC.Gerlach LB, et al.Psychiatr Clin North Am. 2018 Mar;41(1):127-139. doi: 10.1016/j.psc.2017.10.010. Epub 2017 Dec 7.Psychiatr Clin North Am. 2018.PMID:29412841Review.
- Correlates of behavioral disturbances and pattern of psychotropic medication use in five skilled nursing facilities.Ramadan FH, Naughton BJ, Prior R.Ramadan FH, et al.J Geriatr Psychiatry Neurol. 2003 Mar;16(1):8-14. doi: 10.1177/0891988703252177.J Geriatr Psychiatry Neurol. 2003.PMID:12641366
- Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia.Muramatsu RS, Litzinger MH, Fisher E, Takeshita J.Muramatsu RS, et al.Am J Geriatr Pharmacother. 2010 Apr;8(2):98-114. doi: 10.1016/j.amjopharm.2010.03.003.Am J Geriatr Pharmacother. 2010.PMID:20439060Review.
Cited by
- Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S.Huybrechts KF, et al.BMJ. 2012 Feb 23;344:e977. doi: 10.1136/bmj.e977.BMJ. 2012.PMID:22362541Free PMC article.
- Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.Jicha GA, Nelson PT.Jicha GA, et al.Neurodegener Dis Manag. 2011 Apr;1(2):141-156. doi: 10.2217/nmt.11.9.Neurodegener Dis Manag. 2011.PMID:21927623Free PMC article.
- Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S.Huybrechts KF, et al.CMAJ. 2011 Apr 19;183(7):E411-9. doi: 10.1503/cmaj.101406. Epub 2011 Mar 28.CMAJ. 2011.PMID:21444611Free PMC article.
- Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.Schneeweiss S, Setoguchi S, Brookhart MA, Kaci L, Wang PS.Schneeweiss S, et al.CNS Drugs. 2009;23(2):171-80. doi: 10.2165/00023210-200923020-00006.CNS Drugs. 2009.PMID:19173375Free PMC article.
- Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities.Simoni-Wastila L, Ryder PT, Qian J, Zuckerman IH, Shaffer T, Zhao L.Simoni-Wastila L, et al.Am J Geriatr Psychiatry. 2009 May;17(5):417-27. doi: 10.1097/JGP.0b013e31819b8936.Am J Geriatr Psychiatry. 2009.PMID:19390299Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources